Showcasing its technology at the UAB stand and selected to pitch at the BKA Pitch Corner, Bioeclosion presented its portable diagnostic device to investors, partners, and innovation stakeholders at Europe’s leading startup event. Barcelona, March 2026 — Bioeclosion participated in 4YFN-MWC 2026, the startup event held within the Mobile World Congress programme in Barcelona, where the company …
by Isabel Pividori 
BioEclosion will be at Mobile World Congress 2026 (2–5 March, Barcelona) within the UAB stand (8.1C43), exhibiting next-generation biosensor technology for advanced diagnostic devices. BioEclosion will also pitch at the BKA Pitch Corner on 3 March, connecting with investors and partners across the deep-tech ecosystem. BioEclosion will be at Mobile World Congress (MWC) 2026 in …
by Isabel Pividori 
A rapid diagnostic technology developed by BioEclosion and the Universitat Autònoma de Barcelona (UAB) has been assessed by the European Commission’s Innovation Radar and classified as “Market Ready”, with “Market Creation Potential: Noteworthy”. The European Commission, through its Innovation Radar initiative, has evaluated and selected an innovation developed within the EU-funded EChiLiBRiST project. The innovation …
by Isabel Pividori 
A recent study demonstrates a point-of-care electrochemical biosensing workflow to quantify an Alzheimer’s-relevant marker on neuron-origin exosomes isolated from plasma. The assay is implemented in a disposable, magneto-actuated cartridge and the electrochemical signal is acquired using BioEclosion’s portable device. Early diagnosis of Alzheimer’s disease remains one of the major challenges in healthcare, largely because many …
by Isabel Pividori 
Transforming Breast Cancer Diagnosis. BioEclosion’s breakthrough in biosensing technology In an exciting development for the field of medical diagnostics, our latest product, the specialized cartridge for biosensing applications, has been featured in a pioneering study published in Biosensors and Bioelectronics. This study, titled “Peptide-based biosensing approaches for targeting breast cancer-derived exosomes”, marks a significant milestone in …
by Isabel Pividori 
At Bioeclosion, the last month of 2024 has been truly inspiring! As a spin-off from UAB, Bioeclosion participated in the annual ‘Fòrum Arquímedes’ event, which brought together all spin-off companies from the university at the ‘Casa de la Convalescència’ in Barcelona, Spain, on December 10th. It was a networking event aimed at building community and …
by Isabel Pividori We are thrilled to announce that BioEclosion will be participating in 4 Years From Now (4YFN), the premier event for startups, held under the umbrella of the Mobile World Congress (MWC) Barcelona from March 3-6, 2025. As a spin-off of the Universitat Autònoma de Barcelona (UAB), BioEclosion is proud to be among the pioneering companies featured at the UAB stand (8.1C42). At …
by Isabel Pividori 
What a week at 4 Years From Now (4YFN) 2025 Congress held within the Mobile World Congress (MWC) in Barcelona BioEclosion proudly presented its prototype of next-generation biosensor-based diagnostic device at the UAB stand (8.1C42) to 4YFN-MWC attendees. After 4 busy days presenting our patented technology, we are even more commited and motivated to fulfill our mission: enhance early disease detection and …
by Isabel Pividori Input your search keywords and press Enter.